South Korea Ultrasound Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

South korea ultrasound devices market size in 2026 is estimated at USD 177.88 million, growing from 2025 value of USD 170.99 million with 2031 projections showing USD 216.73 million, growing at 4.03% CAGR over 2026-2031. This report is Segmented by Application (Anesthesiology, Cardiology, Obstetrics and Gynecology, Musculoskeletal, and More), Technology (2D Ultrasound Imaging, 3D & 4D Ultrasound Imaging, Doppler Imaging, and More), Portability (Stationary Systems, and More), End User (Hospitals, Diagnostic Imaging Centers, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Units).

South Korea Ultrasound Devices Market Trends and Insights

Rising Geriatric Population & Imaging Demand

By 2025 one in five South Koreans is at least 65, creating sustained ultrasound demand for liver, gallbladder and cardiovascular assessments. Community-care pilots now reimburse in-home scans, encouraging providers to deploy portable units. Rural clinics increasingly rely on pocket devices for chronic-disease monitoring, widening geographic adoption. Hospital administrators report higher sonography workloads, spurring investment in workflow-optimizing AI. While the demographic trend secures volume growth, it tightens budgets and heightens workforce shortages, requiring training incentives for regional technologists.

Government Reimbursement Expansion for Point-of-Care Ultrasound

The NHI cut patient out-of-pocket costs for abdominal and kidney scans by as much as 70%, boosting examination volumes across outpatient sites. Coverage now extends to automated breast ultrasound and musculoskeletal exams, broadening clinical indications. Expanded reimbursement secures predictable cash-flows that justify capital purchases at ASCs. Yet quality-assurance audits reveal variable accuracy when scans are performed by non-physicians, prompting new certification guidelines.

Limited Skilled Sonographers Outside Tertiary Hospitals

A workforce study found 19 labs lacked echocardiography technologists and 18 lacked transcranial Doppler specialists, exposing regional service gaps. Concentration of talent in Seoul tertiary centers restricts ultrasound penetration into community hospitals and ASCs. Pain-management clinics report delays in adopting musculoskeletal scans because physicians must first complete society-run workshops. Unless training capacity scales, device vendors will face uneven regional demand and under-utilized equipment.

Other drivers and restraints analyzed in the detailed report include:

• Technological Advancements in Transducer Miniaturization
• Integration With AI-Based Diagnostic Algorithms
• Stringent Regulatory Approval Timelines

Segment Analysis

Obstetrics & gynecology contributed 28.22% to the South Korea ultrasound devices market size in 2025 after NHI funding for seven prenatal scans cemented routine fetal imaging. AI-enabled anomaly detection, unlocked through Samsung’s Sonio deal, elevates diagnostic yield and cements long-term OEM revenue. Over the forecast, critical care posts the fastest 5.27% CAGR as handheld probes become standard in emergency and intensive-care units. Rising trauma and shock cases in regional centers prompt bulk purchases of pocket scanners. Cardiovascular ultrasound adoption accelerates as Siemens’ Acuson Origin captures 5,000 real-time measurements with 99% accuracy, streamlining echo workflows. Musculoskeletal and urology volumes benefit from newly reimbursed spinal and urinary scans, although uptake depends on training expansion. HIFU-based vascular closure achieves greater than 95% success in varicose-vein treatment, nurturing a therapeutics niche.

Continuous policy backing ensures OB/GYN retains scale, yet competitive intensity rises as GE integrates ScanNav labor analyses, and Philips eyes AI obstetric workflows. Critical care penetration hinges on device ruggedness and infection-control design. Cardiology buyers weigh AI-bundled premium systems against budget limits, delaying replacement decisions. Musculoskeletal growth could falter without credentialing reforms. Vendors targeting vascular and oncology HIFU must navigate separate procedure codes, limiting short-term revenue, but long-term therapeutic diversification remains attractive.

3D & 4D platforms held 39.52% of the South Korea ultrasound devices market share in 2025, propelled by enhanced fetal visualization and real-time cardiac volumetrics. Progressive hospitals now adopt AI abdomen tools for automatic liver and kidney sizing, cutting scan time 36%. HIFU records the highest 4.85% CAGR, driven by prostate, thyroid and aesthetic procedures showing fewer side effects than conventional surgery. 2D imaging remains indispensable for first-line abdominal screening due to lower cost and operator familiarity. Doppler modules gain traction in carotid and peripheral arterial clinics, assisted by AI flow quantification.

Regulatory clarity for therapeutic ultrasound is still evolving, but early adopters leverage MFDS fast-track for novel cancer ablation devices. Local OEMs such as Classis ramp global publications to validate HIFU efficacy. Cost-sensitive clinics continue to prefer versatile 3D/4D consoles over procedure-specific HIFU rigs until reimbursement widens. Deep learning upgrades extend usable life of installed 2D systems, slowing replacement. Technology suppliers balancing advanced features with modular upgrades can defend share while monetizing AI subscriptions.

Complete Report Scope:

• By Application
  • Anesthesiology
  • Cardiology
  • Obstetrics and Gynecology
  • Musculoskeletal
  • Radiology
  • Critical Care
  • Urology
  • Vascular
  • Other Applications
• By Technology
  • 2D Ultrasound Imaging
  • 3D & 4D Ultrasound Imaging
  • Doppler Imaging
  • High-Intensity Focused Ultrasound
  • Other Technologies
• By Portability
  • Stationary Systems
  • Portable Cart-based Systems
  • Hand-held / Pocket Devices
• By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Other End Users

List of Companies Covered in this Report:

• Canon
• GE Healthcare
• Samsung Group
• Siemens Healthineers
• Koninklijke Philips
• FUJIFILM
• Mindray
• Esaote
• SonoScape Medical
• Alpinion Medical Systems
• Healcerion Co. Ltd
• Clarius Mobile Health Corp.
• Butterfly Network Inc.
• BK Medical ApS
• Terason Ultrasound (Teratech)
• Chison Medical Imaging Co. Ltd
• UM Global Co. Ltd
• Shinil Co. Ltd
• Dawei Medical Co. Ltd

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support